The Europe Plasma Fractionation Market would witness market growth of 9.3% CAGR during the forecast period (2021-2027). Plasma fractionation refers to a separation method, which is adopted to extract plasma derivatives. There are various kinds of plasma derivatives accessible in the market such as albumin and immunoglobulins. These products have concentrated fractions of plasma protein, which is extracted with the help of fractionation of plasma collected from a huge number of donors.
Moreover, plasma derivatives are utilized in various medical domains like critical care, neurology, and hematology. For example, immunoglobulins are employed in neurology in order to assist patients who are suffering from multiple sclerosis and neuropathic pain. Furthermore, these products are widely utilized in research labs and hospitals, due to the increasing awareness regarding their usage in several medical domains.
Immunoglobulins are utilized as first-line therapy for several hematologic, immunologic, and neurologic conditions. The primary & common usage of immunoglobulin therapy is considered useful for treating the primary immune deficiencies and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Intravenous immunoglobulin (IVIg) is also being regarded for various neurological disorders, such as neuropathic pain, multiple sclerosis, and chronic fatigue syndrome.
In the past few years, the diagnosis rate of numerous immunological disorders has grown owing to technological developments. Additionally, increasing genetic research for characterizing and diagnosing immunodeficiency will grow the clinical requirement for immunoglobulins because of the higher number of diagnosed patients.
The Germany market dominated the Europe Public Sector Market by Country in 2020, thereby, achieving a market value of $579.9 Million by 2027. The UK market is exhibiting a CAGR of 8.9% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 10.3% during (2021 - 2027).
Based on Product, the market is segmented into Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX. Based on Sector, the market is segmented into Private Sector and Public Sector. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Plasma Fractionation Market Size will Hit $28.2 Billion by 2027, at a CAGR of 9.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Emergent BioSolutions, Inc., CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, LFB S.A, Biotest AG (Tiancheng International Investment Limited), Sanquin Blood Supply Foundation, and Bio Products Laboratory Limited.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
By Sector
- Private Sector
- Public Sector
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Emergent BioSolutions, Inc.
- CSL Limited
- Grifols S.A.
- Octapharma AG
- Takeda Pharmaceutical Company Limited
- Kedrion S.p.A
- LFB S.A
- Biotest AG (Tiancheng International Investment Limited)
- Sanquin Blood Supply Foundation
- Bio Products Laboratory Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Plasma Fractionation Market, by Product
1.4.2 Europe Plasma Fractionation Market, by Sector
1.4.3 Europe Plasma Fractionation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Plasma Fractionation Market by Product
3.1 Europe Immunoglobulins Market by Country
3.2 Europe Albumin Market by Country
3.3 Europe Coagulation factor VIII Market by Country
3.4 Europe Coagulation factor IX Market by Country
Chapter 4. Europe Plasma Fractionation Market by Sector
4.1 Europe Private Sector Market by Country
4.2 Europe Public Sector Market by Country
Chapter 5. Europe Plasma Fractionation Market by Country
5.1 Germany Plasma Fractionation Market
5.1.1 Germany Plasma Fractionation Market by Product
5.1.2 Germany Plasma Fractionation Market by Sector
5.2 UK Plasma Fractionation Market
5.2.1 UK Plasma Fractionation Market by Product
5.2.2 UK Plasma Fractionation Market by Sector
5.3 France Plasma Fractionation Market
5.3.1 France Plasma Fractionation Market by Product
5.3.2 France Plasma Fractionation Market by Sector
5.4 Russia Plasma Fractionation Market
5.4.1 Russia Plasma Fractionation Market by Product
5.4.2 Russia Plasma Fractionation Market by Sector
5.5 Spain Plasma Fractionation Market
5.5.1 Spain Plasma Fractionation Market by Product
5.5.2 Spain Plasma Fractionation Market by Sector
5.6 Italy Plasma Fractionation Market
5.6.1 Italy Plasma Fractionation Market by Product
5.6.2 Italy Plasma Fractionation Market by Sector
5.7 Rest of Europe Plasma Fractionation Market
5.7.1 Rest of Europe Plasma Fractionation Market by Product
5.7.2 Rest of Europe Plasma Fractionation Market by Sector
Chapter 6. Company Profiles
6.1 Emergent BioSolutions, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Grifols S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.1 Recent strategies and developments:
6.3.1.1 Acquisition and Mergers:
6.4 Octapharma AG
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Approvals:
6.4.2.2 Partnerships, Collaborations, and Agreements:
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Kedrion S.p.A
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 LFB S.A.
6.7.1 Company Overview
6.8 Biotest AG (Tiancheng International Investment Limited)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Sanquin Blood Supply Foundation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Bio Products Laboratory Limited
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product Launches and Product Expansions:
TABLE 1 Europe Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 2 Europe Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 3 Europe Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 4 Europe Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 5 Europe Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 7 Europe Albumin Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Albumin Market by Country, 2021 - 2027, USD Million
TABLE 9 Europe Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 12 Europe Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 13 Europe Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 14 Europe Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 15 Europe Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 21 Germany Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 22 Germany Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 23 Germany Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 24 Germany Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 25 Germany Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 26 Germany Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 27 UK Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 28 UK Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 29 UK Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 30 UK Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 31 UK Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 32 UK Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 33 France Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 34 France Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 35 France Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 36 France Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 37 France Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 38 France Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 39 Russia Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 40 Russia Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 41 Russia Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 42 Russia Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 43 Russia Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 44 Russia Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 45 Spain Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 46 Spain Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 47 Spain Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 48 Spain Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 49 Spain Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 50 Spain Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 51 Italy Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 52 Italy Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 53 Italy Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 54 Italy Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 55 Italy Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 56 Italy Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 57 Rest of Europe Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 58 Rest of Europe Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 59 Rest of Europe Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 60 Rest of Europe Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 61 Rest of Europe Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 62 Rest of Europe Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 63 Key Information – Emergent BioSolutions, Inc.
TABLE 64 key Information – CSL Limited
TABLE 65 key information – Grifols S.A.
TABLE 66 Key Information – Octapharma AG
TABLE 67 Key Information – Takeda Pharmaceutical Company Limited
TABLE 68 key Information – Kedrion S.p.A
TABLE 69 Key Information – LFB S.A
TABLE 70 key information – Biotest AG
TABLE 71 Key Information – Sanquin Blood Supply Foundation
TABLE 72 Key Information – Bio Products Laboratory Limited
List of Figures
FIG 1 Methodology for the research